Genentech and the University of Washington are pleased to offer two, 2-year Health Economics and Outcomes Research (HEOR) Fellowship positions for 2020-2022. Fellows will spend their first year at the University of Washington (Seattle, WA) School of Pharmacy, The CHOICE Institute, and the second year at Genentech (South San Francisco, CA).
The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute is housed within the University of Washington School of Pharmacy. Faculty in our program (1) provide advanced research training for graduate students, post-doctoral fellows and clinicians (PharmDs, MDs); (2) conduct rigorous scientific research in economic evaluations and outcomes of pharmaceuticals and other health technologies, and (3) translate and disseminate the results of research into clinical practice and healthcare policy, with the goal of improving patient care. CHOICE faculty participating in the fellowship are dedicated to excellence in their teaching and research. Each is trained either as a health economist or health services researcher and all have an extensive history of effective economic evaluations and pharmacoepidemiologic research.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
The objective of the first year of this fellowship is to educate fellows on the principles and methods used in health economics and outcomes research. During the second year, the fellow will pursue hands-on training in strategically focused health economics and outcomes to support commercialization of Genentech’s products. The fellow will work closely with colleagues in the Evidence for Access organization, which is comprised of HEOR and Health Systems Researchers, in Genentech’s US Medical Affairs organization.
Compensation includes a competitive stipend, basic medical insurance, conference attendance, full tuition coverage for the MS program, and holiday/vacation time. A Master’s (MS) Degree is awarded upon completion of all course requirements and thesis project.
Application Instructions: Our PPS Application priority deadline is November 29, 2019. Please submit the following via PPS to request an interview with us at PPS:
Three formal letters of recommendation should be either submitted via PPS or sent directly to firstname.lastname@example.org (by the applicant or the letter writer) no later than December 13, 2019. NOTE: We welcome letters to be submitted earlier than this to be taken into consideration for your interview request. You may combine any materials as a single PDF file to circumvent the file upload limit in PPS.
Contact Marina Gano, email@example.com, the Graduate Program and Operations Manager for the CHOICE Institute with questions about applying.
Applicants for this fellowship must have a degree in pharmacy and have some research experience (preference will be given to those with a high academic standing). Excellent written and verbal communication skills are also essential.
Selection of fellows will be made by a steering committee composed of the University of Washington faculty members and representatives from Genentech.
Due to visa restrictions, we can only consider applicants who are U.S. citizens or Permanent Residents (green card holders).